Petr Krivorotko, Evgeny Imyanitov, Diana Enaldieva, Anna Sokolenko, Roman Donskih, Larisa Gigolaeva, Arina Gorina, Mariam Dzhelialova, Tatiana Semiglazova, Vladimir Semiglazov. "Neoadjuvant mitomycin C plus carboplatin followed by paclitaxel vs. standard doxorubicin–cyclophosphamide followed by paclitaxel–carboplatin in BRCA1/2-associated breast cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.620